In 2 cases, the presence of ERBB2 duplication prompted additional immunohistochemical analysis with mammaglobulin, GATA3, and GCDFP, which ultimately led to diagnosis of HER2 positive breast carcinoma. The gene discussed is GATA3; the disease is breast carcinoma.